期刊名
ANGIOGENESIS

ANGIOGENESIS

ISSN / eISSN
0969-6970 / 1573-7209
目标和范围
Angiogenesis is an international peer-reviewed journal devoted to the publication of top quality original articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis in physiological and pathological conditions. As a central source for rapid communications representing the full spectrum of angiogenesis research, this multidisciplinary journal publishes innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases. Angiogenesis also reports on novel therapeutic approaches for promoting or inhibiting angiogenesis as well as new markers and techniques for disease diagnosis and prognosis.
研究方向

外周血管病

CiteScore
18.80 查看趋势图
CiteScore 学科排名
类别 分区 排名
Biochemistry, Genetics and Molecular Biology - Clinical Biochemistry Q1 #2/113
Biochemistry, Genetics and Molecular Biology - Physiology Q1 #6/182
Biochemistry, Genetics and Molecular Biology - Cancer Research Q1 #16/214
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
PERIPHERAL VASCULAR DISEASE - SCIE Q1
H-index
80
出版国家或地区
NETHERLANDS
出版商
Springer Netherlands
出版周期
Quarterly
出版年份
1997
年文章数
33
Open Access
NO
通讯方式
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
The submission took one week to reach the editor's hands, and it took the editor 16 days to decide whether to send it for review or reject it. It is indeed a bit slow.

Editorial decision: Reject without review
On 09 Apr, 2022

Editor assigned
On 24 Mar, 2022

First submitted to Angiogenesis
On 18 Mar, 2022
2022-04-09

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started